Sendler Matthias, Maertin Sandrina, John Daniel, Persike Maria, Weiss F Ulrich, Krüger Burkhard, Wartmann Thomas, Wagh Preshit, Halangk Walter, Schaschke Norbert, Mayerle Julia, Lerch Markus M
From the Department of Medicine A, University Medicine Greifswald, 17489 Greifswald, Germany.
the Division of Medical Biology, University of Rostock, 18057 Rostock, Germany.
J Biol Chem. 2016 Jul 8;291(28):14717-31. doi: 10.1074/jbc.M116.718999. Epub 2016 May 12.
Pancreatitis is associated with premature activation of digestive proteases in the pancreas. The lysosomal hydrolase cathepsin B (CTSB) is a known activator of trypsinogen, and its deletion reduces disease severity in experimental pancreatitis. Here we studied the activation mechanism and subcellular compartment in which CTSB regulates protease activation and cellular injury. Cholecystokinin (CCK) increased the activity of CTSB, cathepsin L, trypsin, chymotrypsin, and caspase 3 in vivo and in vitro and induced redistribution of CTSB to a secretory vesicle-enriched fraction. Neither CTSB protein nor activity redistributed to the cytosol, where the CTSB inhibitors cystatin-B/C were abundantly present. Deletion of CTSB reduced and deletion of cathepsin L increased intracellular trypsin activation. CTSB deletion also abolished CCK-induced caspase 3 activation, apoptosis-inducing factor, as well as X-linked inhibitor of apoptosis protein degradation, but these depended on trypsinogen activation via CTSB. Raising the vesicular pH, but not trypsin inhibition, reduced CTSB activity. Trypsin inhibition did not affect apoptosis in hepatocytes. Deletion of CTSB affected apoptotic but not necrotic acinar cell death. In summary, CTSB in pancreatitis undergoes activation in a secretory, vesicular, and acidic compartment where it activates trypsinogen. Its deletion or inhibition regulates acinar cell apoptosis but not necrosis in two models of pancreatitis. Caspase 3-mediated apoptosis depends on intravesicular trypsinogen activation induced by CTSB, not CTSB activity directly, and this mechanism is pancreas-specific.
胰腺炎与胰腺中消化蛋白酶的过早激活有关。溶酶体水解酶组织蛋白酶B(CTSB)是已知的胰蛋白酶原激活剂,其缺失可降低实验性胰腺炎的疾病严重程度。在此,我们研究了CTSB调节蛋白酶激活和细胞损伤的激活机制及亚细胞区室。胆囊收缩素(CCK)在体内和体外均增加了CTSB、组织蛋白酶L、胰蛋白酶、糜蛋白酶和半胱天冬酶3的活性,并诱导CTSB重新分布至富含分泌囊泡的组分中。CTSB蛋白和活性均未重新分布至富含CTSB抑制剂胱抑素B/C的胞质溶胶中。CTSB的缺失减少了细胞内胰蛋白酶的激活,而组织蛋白酶L的缺失则增加了这种激活。CTSB的缺失还消除了CCK诱导的半胱天冬酶3激活、凋亡诱导因子以及凋亡蛋白X连锁抑制剂的降解,但这些均依赖于CTSB介导的胰蛋白酶原激活。提高囊泡pH值可降低CTSB活性,但抑制胰蛋白酶则无此作用。抑制胰蛋白酶并不影响肝细胞的凋亡。CTSB的缺失影响腺泡细胞的凋亡,但不影响坏死。总之,胰腺炎中的CTSB在分泌性、囊泡性和酸性区室中被激活,在该区室中它激活胰蛋白酶原。在两种胰腺炎模型中,其缺失或抑制可调节腺泡细胞凋亡,但不影响坏死。半胱天冬酶3介导的凋亡依赖于CTSB诱导的囊泡内胰蛋白酶原激活,而非CTSB的直接活性,且这种机制具有胰腺特异性。